Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

kinetics

  • First-in-Humans Study of <sup>68</sup>Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
    Open Access
    First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
    Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Pirilä, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen and Anne Roivainen
    Journal of Nuclear Medicine April 1, 2021, 62 (4) 577-583; DOI: https://doi.org/10.2967/jnumed.120.250696
  • You have access
    Reference Tissue–Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
    Suzanne L. Baker, Samuel N. Lockhart, Julie C. Price, Mark He, Ronald H. Huesman, Daniel Schonhaut, Jamie Faria, Gil Rabinovici and William J. Jagust
    Journal of Nuclear Medicine February 1, 2017, 58 (2) 332-338; DOI: https://doi.org/10.2967/jnumed.116.175273
  • You have access
    Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
    Sergey Shcherbinin, Adam J. Schwarz, Abhinay Joshi, Michael Navitsky, Matthew Flitter, William R. Shankle, Michael D. Devous and Mark A. Mintun
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1535-1542; DOI: https://doi.org/10.2967/jnumed.115.170027
  • You have access
    Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects
    Malene Trägårdh, Niels Møller and Michael Sørensen
    Journal of Nuclear Medicine September 1, 2015, 56 (9) 1366-1371; DOI: https://doi.org/10.2967/jnumed.115.154211
SNMMI

© 2025 SNMMI

Powered by HighWire